47 people died of Covid-19 this Wednesday, May 25 at the hospital, according to the daily report of the organization Public Health France.
16,133 patients are also hospitalized in French hospitals (against 16,510 on Tuesday), including 584 who arrived in the last 24 hours.
Read the dossierCovid-19: the coronavirus pandemic in figures and infographics
Among them, 1043 patients are treated in critical care units.
24 hours earlier, they were 1072.
What to remember from this Wednesday
Health authorities on Wednesday recommended a new vaccine booster in the fall for all people at risk, including this time those with comorbidities.
People aged at least 60 and the immunocompromised could already receive a second booster dose.
From now on, other French people at risk of serious forms of the disease, such as diabetics, the obese or even people with psychiatric disorders, would be eligible.
The objective is to
“anticipate”
to
“limit the impact of a future wave, in particular on the most fragile”.
The Omicron BA-5 variant has become dominant in Portugal, a country currently facing a new spike in Covid-19 contaminations in recent weeks, according to health authorities.
The BA-5 subvariant, detected for the first time in Portugal at the end of March, is experiencing
“a strong increase”
and was
“dominant”
in the country on May 23.
It is at the origin of
"nearly 80% of new cases"
, told AFP a spokesperson for the National Institute of Health (INSA), which published a report on Covid-19 on Tuesday evening. .
The city of Beijing has sacked a senior health official as the shadow of a lockdown hangs over the Chinese capital, state media reported on Wednesday.
China has been facing a resurgence of the Covid-19 epidemic for several months, which is affecting several parts of the country to varying degrees.
Beijing city health official Yu Luming is being investigated on suspicion of
"serious violations of discipline and the law
," Xinhua said.
The American pharmaceutical giant Pfizer pledged on Wednesday to sell some of its drugs and vaccines at cost to 45 poor countries, as part of an initiative announced at the Davos Economic Forum.
“With all that we have learned and accomplished over the past two years, now is the time to begin to further close the gap”
between
“those who can access these innovations and those who cannot
,” said the CEO. of the pharmaceutical giant, Albert Bourla, during a press conference presenting the initiative in Switzerland.
